Clinical trial
Effectiveness of Levetiracetam in the Treatment of Body Dysmorphic Disorder
NCT00265109 · Butler Hospital, Other · Completed
Key facts
| NCT number | NCT00265109 |
|---|---|
| Title | Effectiveness of Levetiracetam in the Treatment of Body Dysmorphic Disorder |
| Official title | Open-Label Study of Levetiracetam in Body Dysmorphic Disorder |
| Lead sponsor | Butler Hospital, Other |
| Collaborators | UCB Pharma Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Body Dysmorphic Disorder |
| Intervention type | Drug |
| Interventions | Levetiracetam |
| Enrollment | 17 |
| Start date | Dec 1, 2004 |
| Primary completion | Jan 1, 2008 |
| Completion | Jan 1, 2008 |
| First posted | Dec 14, 2005 |
| Last update posted | Aug 29, 2019 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: